Richard J. Rubino
2018
In 2018, Richard J. Rubino earned a total compensation of $3M as Chief Financial Officer, Secretary and Treasurer at Aerie Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,500 |
|---|---|
| Option Awards | $1,785,832 |
| Salary | $450,000 |
| Stock Awards | $571,218 |
| Other | $5,625 |
| Total | $2,988,175 |
Rubino received $1.8M in option awards, accounting for 60% of the total pay in 2018.
Rubino also received $175.5K in non-equity incentive plan, $450K in salary, $571.2K in stock awards and $5.6K in other compensation.
Rankings
In 2018, Richard J. Rubino's compensation ranked 3,881st out of 14,244 executives tracked by ExecPay. In other words, Rubino earned more than 72.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,881 out of 14,244 | 73rd |
Division Manufacturing | 1,433 out of 5,765 | 75th |
Major group Chemicals And Allied Products | 510 out of 2,128 | 76th |
Industry group Drugs | 427 out of 1,817 | 77th |
Industry Biological Products, Except Diagnostic Substances | 89 out of 339 | 74th |
Source: SEC filing on April 10, 2019.
Rubino's colleagues
We found four more compensation records of executives who worked with Richard J. Rubino at Aerie Pharmaceuticals in 2018.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019